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In situ versus extra-anatomic reconstruction for
primary infected infrarenal abdominal aortic
aneurysms
Chun-Hui Lee, MD,a Hung-ChangHsieh, MD,b Po-Jen Ko, MD,b Hao-Jui Li, MD,b Tsung-Chu Kao, MD,b
and Sheng-Yueh Yu,MD,b Taoyuan, Taiwan
Background: There is no standard procedure for revascularization after infected infrarenal abdominal aortic aneurysm
resection. This study examines the outcomes of two contemporary methods.
Methods:We retrospectively reviewed medical records for patients who underwent repair of infected infrarenal abdominal
aortic aneurysms from January 1998 to December 2007 at a single institution. Patients with infected prosthetic aortic
grafts were excluded.
Results: Twenty-eight patients (22 men; mean age, 65 12) had in situ graft (group I, n 13) or extra-anatomic bypass
(group II, n  15), with a mean follow-up of 22 months. Mean hospital lengths of stay were 36  16 days for group I
and 46 17 days for group II. Overall perioperative mortality was 5 of 28 (18%), comprising 1 of 13 in group I (8%) and
4 of 15 in group II (27%; P .333). No early or late vascular-related complications occurred in group I. In group II, three
patients had early vascular-related complications, including, graft infection, graft occlusion and ischemia colitis, and five
patients had late vascular-related complications, including graft infection and graft occlusion. One patient ultimately lost
a limb. Group I had a 0% late complication rate vs 33% in group II (P  .044). For cumulative survival rates,
Kaplan-Meier analysis and log-rank testing revealed no significant differences between groups I and II.
Conclusion: In situ graft revascularization is viable in afebrile patients or patients who have good response to preoperative
antibiotic therapy. Extra-anatomic bypass grafting for infected infrarenal abdominal aneurysm resection has a similar
long-term survival rate and should be considered in patients who are unsuitable for in situ graft revascularization;
however, the postoperative complication rate is higher. Further prospective study with large patient populations is needed
to determine the selection criteria for using in situ revascularization as alternative methods for treatment of infected
abdominal aneurysms. (J Vasc Surg 2011;54:64-70.)
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aIn 1885, Sir William Osler described a patient who died
after a period of cough, fever, chills, headache, and diar-
rhea. Autopsy showed aortic valve vegetation and multiple
beadlike aneurysms of the aortic arch resulting from sup-
puration in the vessel wall.1 The term mycotic aneurysm was
thus coined to describe “an abnormal dilatation of an
arterial wall induced by bacterial or mycotic infection.”
This term seems a misnomer nowadays because fungal
infections are rare; some authors prefer to use the term
infected aneurysm. Infected aneurysms of the aorta and
adjacent arteries are difficult to treat. Even with the 20th
century’s great advances in medical care, surgery, and post-
operative care, infected aneurysms of the aorta remain
lethal.
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64The conventional treatment strategy for an infected
neurysm of the infrarenal aorta has been surgical resection
f the infected aneurysm, extensive debridement of the
urrounding soft tissue, and revascularization, followed by
ong-term antibiotic therapy.2-5 The traditional method for
evascularization is extra-anatomic bypass.3,6-8 However,
ome authors advocate in situ interposed graft as an alter-
ative revascularization method. Neither treatment has
merged as a favorite for revascularization after infected
neurysm resection.8-11
The current study reviews our experiences managing
8 patients with infected aneurysms of the infrarenal ab-
ominal aorta and examines the clinical outcome of in situ
nd extra-anatomic bypass prosthetic graft revasculariza-
ion.
ATIENTS AND METHODS
After approval by the Institutional Review Board of
hang Gung Memorial Hospital, a retrospective medical
ecord review was performed for all patients who under-
ent resection of infected infrarenal abdominal aortic an-
urysms (AAAs) by a single vascular surgery group from
anuary 1998 to December 2007. Patients with infected
rosthetic aortic grafts were excluded.
Infected aneurysm diagnosis was confirmed if there was
positive culture taken from the aneurysm wall or sur-ounding tissue along an abscess surrounding the aneurysm
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Volume 54, Number 1 Lee et al 65or if the patient displayed signs of infection without other
apparent sources.
Surgical procedures. All stable patients with sus-
pected infected AAAs were given empiric antibiotics for 7
days before surgery. Patients who had a free-ruptured an-
eurysm or unstable hemodynamic status underwent emer-
gent operations without preoperative antibiotic therapy.
Surgical procedures included debridement of necrotic tis-
sue, copious saline irrigation, and reconstruction with an in
situ prosthetic graft or extra-anatomic bypass. Segments of
the infected aneurysm wall were cultured for bacteria. In
our institution, extra-anatomic bypass is the first choice for
revascularization after infected aneurysm resection. In situ
prosthetic graft was selected for patients who were afebrile
before emergent operations or had good response to pre-
operative antibiotic therapy. Good response to antibiotic
therapy was defined as reduced fever, declining white blood
cell count and C-reactive protein levels, and no hemody-
namic deterioration (systolic blood pressure 100 mm
Hg).
For patients who underwent in situ prosthetic graft
replacement (group I), aortic anastomosis was performed
with a simple clamp-and-sew method through a midline
laparotomy; a Dacron graft was used for in situ reconstruc-
tion. Grafts were not soaked in rifampin or impregnated
with gelatin before implantation. The in situ prosthetic
graft was covered with a vascularized omental flap.
In patients who underwent extra-anatomic bypass
(group II), an 8-mm expanded polytetrafluoroethylene
(ePTFE) prosthetic graft was implanted for axillofemoral
bypass and a 6-mm ePTFE prosthetic graft was used for
femorofemoral bypass. The proximal and distal aortas (or
iliac arteries) were ligated with nylon tape, and stumps were
sutured with 4-0 polypropylene sutures. A vascularized
omental flap was also mobilized to cover the aortic stump.
Postoperative management. Intravenous antibiotics
were administered for at least 6 weeks after surgery or until
clinical and laboratory parameters, including body temper-
ature, white cell count, and C-reactive protein level normal-
ized. Patients underwent computed tomography imaging
before discharge to ensure no residual infection.
Data collection. Medical records were reviewed for
age, sex, presenting symptoms and signs, including abdom-
inal pain, back pain, fever (38°C), leukocytosis (white
blood cell count 12,000 cells/mm3), leukocytopenia
(white blood cell count4000 cells/mm3), hemodynamic
status, results of bacteriologic culture, surgical procedures,
and clinical outcome.
Clinical events were classified as early and late. The early
or perioperative period was defined as the in-hospital pe-
riod, without regard to number of days after surgery. Early
or perioperative mortality was defined as death from any
cause during hospitalization; late mortality was defined as
death related to an infected aneurysm or to surgery after
discharge. Complications were classified as vascular-related
and non-vascular-related. Vascular-related complications
were defined as ischemia colitis, stump rupture, graft infec-
tion, graft occlusion, and limb loss. We attempted to ascer-ain if complications were surgery-related and whether they
ere the direct causes of death.
Statistical analysis. Categoric variables were com-
ared using 2 or the Fisher exact test. Means were com-
ared using the t test, with P values .05 deemed signifi-
ant. We generated Kaplan-Meier survival curves between
he in situ graft and extra-anatomic bypass groups. Log-
ank testing was done to find significant differences in
urvival between the study populations. All analysis was
one using SPSS 15.0 software (SPSS Inc, Chicago, Ill).
ESULTS
During the study period, 28 patients (22 men) with a
ean age of 65  12 (range, 48-83 years) underwent
esection for an infected aortic aneurysm. These included
3 in situ (group I) and 15 extra-anatomic bypasses (group
I) for revascularization after infected infrarenal AAA resec-
ion. Six patients underwent emergency surgery, of whom
hree patients had free-ruptured aneurysms and the other
hree had unstable hemodynamic status. Two patients who
ere afebrile underwent in situ prosthetic graft reconstruc-
ion and the other four patients, who were febrile, under-
ent aneurysm resection, followed by extra-anatomic by-
ass. The other 22 stable patients received preoperative
ntibiotic therapy. Two of these 22 patients had early
urgery for uncontrolled infection and extra-anatomic by-
ass graft reconstruction.
able I. Patient demographics and initial clinical
resentation
ariablea
Group Ib
(n  13)
Group IIc
(n  15) P
ge, y 68  12 64  12 .420
ale sex 8 (62) 14 (93) .069
ymptoms/signs
Abdominal pain 12 (92) 11 (73) .333
Fever 5 (39) 12 (80) .051
Back pain 3 (23) 8 (53) .137
Leukocytosis (12,000
cells/mm3) 5 (39) 8 (53) .476
Leukocytopenia (4000
cells/mm3) 0 (0) 2 (13) .484
Hemodynamic instabilityd 2 (16) 4 (27) .655
tatus of rupture
Contained rupture 7 (54) 11 (73) .433
Free rupture 2 (15) 1 (7) .583
Intact 4 (31) 3 (20) .670
eriaortic abscess 5 (39) 8 (40) .476
acteria
Salmonella spp 7 (54) 14 (93) .029
No growth 3 (23) 2 (10) .087
ORSA 1 (8) 1 (7) .99
Klebsiella pneumoniae 1 (8) 0 (0) .464
Fusobacterium spp 1 (8) 0 (0) .464
RSA, Oxacillin-resistant Staphylococcus aureus.
Data are presented as number (%) or mean  standard deviation.
In situ graft.
Extra-anatomic bypass.
Defined as systolic blood pressure 100 mm Hg.Table I reports initial clinical presentation characteris-
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July 201166 Lee et altics for groups I and II. Men comprised 62% and 93% of
their respective populations, although this difference was
not significant (P  .069). Group II had a higher rate of
Salmonella-positive culture (93%, P  .029).
Groups I and II were similar in age, rupture status, and
initial clinical presentations such as abdominal pain, back
pain, hemodynamic status, leukocytosis (12,000 cells/
mm3) and leukocytopenia (4000 cells/mm3). Fever oc-
curred in 17 patients initially, but only five patients were
afebrile before operation and received in situ prosthetic
graft reconstruction (P  .051). The other 12 patients
received extra-anatomic reconstruction. Preoperative im-
age studies or intraoperative findings documented periaor-
tic abscess in five patients in group I and in eight patients in
group II, but the difference between these two groups was
not significant (P  .476).
Early outcomes. The mean lengths of hospital stay
were 36 16 days for group I and 46 17 days for group
II, which was not significantly different. Overall perioper-
ative mortality was 18% (5 of 28), and there were no
significant differences between the extra-anatomic bypass
(4 of 15, 27%) and in situ (1 of 13, 8%) populations (Table
II). Four patients (27%) who underwent extra-anatomic
reconstruction died of severe sepsis during the periopera-
tive period. One group I patient (8%) died of pneumonia-
induced respiratory failure at 24 days after surgery (Table
III).
Among the 13 patients treated with in situ reconstruc-
tion of infected infrarenal aortic aneurysms, four (31%) had
perioperative complications; none were early vascular-
related complications, but they did include three with
pneumonia and one patient each with transient renal fail-
ure, wound dehiscence, wound infection, and perforated
peptic ulcer.
Among the 15 patients who received extra-anatomic
bypass, 10 patients (67%) had perioperative complications
(Table II). Vascular-related complications developed in
three patients, including ischemia colitis in two, graft oc-
clusion in one, and graft infection in one. The patient who
had graft occlusion developed graft infection after throm-
bectomy. In this patient, the graft was salvaged successfully
Table II. Clinical outcomes
Variablea
Group Ib
(n  13)
Group IIc
(n  15) P
Hospitalization, days 36  16 46  17 .136
Perioperative mortality 1 (8) 4 (27) .333
Early complications 4 (31) 10 (67) .128
Vascular-related 0 (0) 3 (20) .226
Non-vascular-related 4 (31) 8 (53) .276
Late complications 0 (0) 5 (33) .044
Vascular-related 0 (0) 5 (33) .044
Non-vascular-related 0 (0) 1 (7) .99
aData are presented as number (%) or mean  standard deviation.
bIn situ graft.
cExtra-anatomic bypass.after thrombectomy, aggressive debridement, and antibi- rtic treatment. In group II, eight patients (53%) had peri-
perative non-vascular-related complications, including
hree with intra-abdominal or retroperitoneal abscess, two
atients each with perforated peptic ulcer, pneumonia,
ransient renal failure, and respiratory failure requiring pro-
onged ventilation and one patient each with acute pulmo-
ary edema, myocardial infarction, and wound infection.
roup II had a higher rate of perioperative complications
67%) than group I, but there was no statistical difference
etween these two groups (P  .128). The relation be-
ween number of perioperative mortality and preoperative
mage findings is reported in Table IV.
Late outcomes. Surviving patients had a median
ollow-up of 10 months, with a mean follow-up of 22
onths (range, 1-125 months). No late aneurysm-related
eaths occurred in this series (Table III).
Late vascular-related complications developed in five
atients (33%) in group II, including graft occlusion and
raft infection (Table III). Three of these patients had only
ad a graft occlusion episode. One patient received throm-
ectomy, and the graft remained patent. Intimal hyperpla-
ia developed in one patient that caused stenosis at the
nastomosis. He underwent revision of extra-anatomic by-
ass, and the new graft remained patent. The last patient
7%) required amputation after a salvage procedure.
Two other patients had both graft occlusion and graft
nfection. One patient underwent thrombectomy, bilateral
emoropopliteal bypass grafts, resection of the segmental
nfected graft, and revision of the extra-anatomic bypass
raft. This patient also had an early graft occlusion episode,
nd the repeat graft occlusion episodes were related to
ilateral superficial femoral artery stenosis (Table III). The
ther patient underwent thrombectomy, debridement, and
evision of a femorofemoral bypass graft, followed by mus-
le flap coverage. The extra-anatomic bypass grafts of these
wo patients were patent after aggressive salvage procedures
nd there was no limb loss.
The overall reoperation rate for graft salvage was 33%
5 of 15). A wound infection developed in one patient (7%)
n group II during follow-up. The late complication rate
as significantly different between those who underwent in
itu (0%) and extra-anatomic bypass (33%; P  .044).
roup II also had more vascular-related complications
P  .044). Kaplan-Meier cumulative survival curves (Fig)
howed no significant differences between the two groups.
ISCUSSION
Infected AAAs are rare but life-threatening. The litera-
ure indicates long-term antibiotic treatment and aneurysm
xcision. Controversy exists concerning revascularization
ptions for infrarenal infected AAAs. The contents of the
nfected aneurysmal sac are responsible for sepsis, as proven
y the high incidence of positive tissue cultures during
urgery.4 In situ prosthetic graft reconstruction has the
otential to expose these patients to graft infection. Expe-
iences with in situ graft infection management led to
nfected graft excision with extra-anatomic bypass as a
ecommended treatment.
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Volume 54, Number 1 Lee et al 67Extra-anatomic bypass should reduce the risk of graft
infection because revascularization is performed remotely
from the infection site, making it a “no-touch” tech-
nique.4,6,12 Besides, the major advantage of this staged
extra-anatomic bypass reconstruction could decrease car-
diac afterload and leg ischemia time during aneurysm re-
section. We performed this technique in group II patients,
except for four patients who had free-ruptured aneurysms
or unstable hemodynamic status before operation. In these
unstable patients, there was no time to access the ho-
Table III. The relation of vascular complication and aneu
Pt Groupa Organism
Early vascular
complication Procedure
1 I No growth No . . .
14 II Salmonella No . . .
15 II Salmonella No . . . G
16 II Salmonella Graft occlusion Thrombectomy G
Graft infection Resection of the
segmental
infected graft,
segmental
graft bypass
G
19 II ORSA No . . .
20 II Salmonella No . . . G
21 II Salmonella Ischemia colitis Nob
23 II Salmonella No . . . G
26 II Salmonella Ischemia colitis Hartmann
procedure
27 II Salmonella No . . . G
G
Ax-biFem, Axillobifemoral; ePTFE, expanded polytetrafluoroethylene; femfe
coccus aureus.
aGroup I received in situ prosthetic graft; group II received extra-anatomic
bPatient died of septic shock before further intervention.
Table IV. The relation of preoperative image findings
and perioperative death
Pre-op image
findings
Group I (n  13) Group II (n  15)
Pts Peri-op death Pts Peri-op death
No. No. (%) No. No. (%)
Rupture 9 0 (0) 12 4 (27)
Contained rupture 7 0 (0) 11 3 (20)
Free rupture 2 0 (0) 1 1 (7)
Intact 4 1 (8) 3 0 (0)
Periaortic abscess 5 0 (0) 8 2 (13)mograft for a neoaortoiliac system (NAIS) reconstruction. iSome surgeons may select in situ prosthetic graft in this
ritical situation. Adequate preoperative parenteral antibi-
tic therapy is crucial11,13 but is impossible for these critical
atients. On the other hand, Salmonella-induced primary
nfected AAAs were more rampant in Asia than in the
est.5,8,11,14 In the review of Soeavia-Dunand et al15 in
he last century, extra-anatomic bypass had a better survival
ate in Salmonella aortitis. According to these studies,
xtra-anatomic bypass was still the first choice in these
ritical patients in our series, except in patients who had
ood response to antibiotic therapy. However, infected
rosthetic aortic graft management studies have noted a
igh incidence of complications for extra-anatomic bypass,
ncluding an 8% to 19% rate of aortic stump disruption, 17%
o 27% rate of amputation, and an 8% to 22% rate of
einfection.16-21 Although no aortic stump disruption nor
einfection developed in the 15 patients in group II, limb
oss did occur in one patient during follow-up, for a 7%
mputation rate. Concerning the potential risk of limb loss,
n situ graft reconstruction may be optimal for management
f infrarenal aortic aneurysms.
There is only one practical approach for patients with
-related mortality
ascular
lication Procedure Death
Aneurysm-related
death
. . . . . Early Pneumonia-induced
respiratory failure
. . . . . Early Sepsis
usion
Thrombectomy, left
below-knee
amputation
Alive . . .
nfection Resection of the
segmental infected
graft, redo right
Ax-biFem bypass
Alive . . .
usion
Thrombectomy,
bilateral fempop
bypass
. . . . . Early Sepsis
usion
Thrombectomy Alive . . .
. . . . . Early Sepsis
usion
Thrombectomy, redo
Ax-biFem bypass
Alive . . .
. . . . . Early Sepsis
usion
Thrombectomy Alive . . .
nfection Debridement, infected
graft resection,
femfem bypass with
new ePTFE graft,
muscle flap coverage
orofemoral; fempop, femoropopliteal; ORSA, oxacillin-resistance Staphylo-
s graft.rysm
Late v
comp
.
.
raft
occl
raft i
raft
occl
.
raft
occl
.
raft
occl
.
raft
occl
raft i
m, femnfected suprarenal aortic aneurysm. Graft replacement
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July 201168 Lee et alstudies under these circumstances found in situ prosthetic
graft reconstruction was satisfactory22-25 and advocated in
situ prosthetic graft reconstruction as being viable for re-
vascularization after infrarenal infected aortic aneurysm
resection. However, Kyriakides et al26 reviewed the litera-
ture and reported that 20% of survivors of in situ recon-
struction need a subsequent extra-anatomic bypass graft
after infection of the initial graft. These disappointing
results rekindled the doubt concerning the safety and effi-
cacy of this technique. Atnip et al22 indicated that in situ
prosthetic graft replacement requires drainage and debride-
ment, along with prolonged parenteral antibiotic therapy
and permanent suppressive oral antibiotics.
In 1993, Fichelle et al9 reported their experiences with
25 patients who had infected infrarenal aortic aneurysms
and reviewed 106 cases in the literature between 1968 and
1989 to determine in situ reconstruction safety. They sug-
gested that if the infection is limited and no osteomyelitis is
noted in preoperative computed tomography scanning, in
situ reconstruction of the infected aneurysm can be per-
formed safely under certain conditions, such as when the
resection is complete, with removal of the neighboring
Fig. Kaplan-Meier survival curve demonstrates similar
anatomic bypass graft group. P  .358 (log-rank test).aortic and retroperitoneal tissue. Anastomosis should also ce done on healthy tissue only. A pediculated omental flap
hould cover the prosthesis, and all sutures and adequate
ntibiotic therapy should be instituted promptly.
Kyriakides et al26 suggested that in situ prosthetic graft
eplacement should be performed for selected patients
nly, including those with low-grade infection as indicated
y an absence of a purulent aortic bed. Ting et al27 sug-
ested that in situ reconstruction with a prosthetic graft is
ndicated unless there is severe infection with purulence
resented. In a recent study, Hsu et al10 reviewed patients
ith mycotic aneurysms complicated by psoas abscess and
oncluded that these abscesses are a contraindication to in
itu prosthetic graft replacement. Woon et al8 have sug-
ested that in situ graft replacement is appropriate only for
atients with limited purulence or less virulent infection, or
oth, and suprarenal, juxtarenal, or infrarenal with short
eck (1 cm).
Compared with these studies, we performed in situ
rosthetic graft reconstruction in patients with periaortic
bscess. Surgical outcome of infected aneurysm was related
o the host immune response against sepsis.28,29 In patients
ho had reduced fever and a declined white blood cell
-term survival between in situ graft group and extra-longount and C-reactive protein level after preoperative anti-
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Volume 54, Number 1 Lee et al 69biotic therapy, we used in situ prosthetic graft reconstruc-
tion. Eight patients in group I had periaortic abscess, but
these patients all survived without graft infection. From the
experience of Luo et al,14 they emphasized that prolonged
preoperative and postoperative antibiotic therapy and ade-
quate and extensive debridement are crucial for successful
in situ graft reconstruction. Nevertheless, infection remains
a potential risk with in situ graft reconstruction. In the face
of severe infection, surgeons still prefer extra-anatomic
bypass revascularization.4,8,30
With time, extra-anatomic bypass grafting techniques
have improved and yielded better results. Yeager et al31
studied 60 patients who underwent axillobifemoral bypass
grafting for infrarenal aortic infection. The perioperative
mortality was 20% for primary infection cases, and the
overall reoperation rate was 14%. However, the infection
rate was only 10%, and the 5-year graft patency rate was
68%. This study indicated that conventional surgical tech-
niques are improving and now comparable to alternatives
such as aortic allograft or femoral vein graft. Soeavia-
Dunand et al15 reviewed 92 patients with Salmonella aor-
titis who underwent in situ or extra-anatomic bypass graft-
ing. The axillobifemoral grafts had fewer postoperative
complications and had a 71% survival rate compared with
51% for in situ grafts.15 According to the results of these
studies, the conventional surgical option—extra-anatomic
bypass—provides an important option in aneurysms with
high-grade infection.
Compared with the mentioned studies, our results
seemed to be disappointing. According to a previous re-
port, survival rate depended on the rupture status of the
aneurysm.4 Aneurysm rupture rate was higher in our group
II patients preoperatively, and it may imply more severe
infection. Group II patients also had poor response to
antibiotic therapy. The severe infection may cause periop-
erative unstable hemodynamic status that results in extra-
anatomic bypass graft occlusion. This poor result was prob-
ably because of a negative selection in these patients.
The current data note that the early complication rate
for extra-anatomic bypass is high. Moreover, the early
vascular-related complication rate is also high for the extra-
anatomic bypass graft group. However, these rates were
better than those for studies done in 1980 and 1990. Our
data show the late vascular-related complication and overall
late complication rates were higher in the extra-anatomic
bypass graft group than in the in situ graft group.
In terms of complication rate and long-term survival, in
situ prosthetic graft reconstruction seems to be the pre-
ferred surgical option after resection of infected infrarenal
aortic aneurysms, although preoperative antibiotic therapy,
meticulous intraoperative debridement, prolonged postop-
erative antibiotic therapy, and graft infection vigilance are
all required.
In the current consensus, extra-anatomic bypass revas-
cularization replacement is efficacious in patients present-
ing with severe infection, manifesting extensive purulence,
and with complications such as vertebral erosion or osteo-
myelitis and retroperitoneal or psoas abscess; however, itas disadvantages, including a longer operating time and
imb ischemia time, and potential risks of limb loss, graft
cclusion, and aortic stump blowout.
Except for prosthetic grafts, other options of in situ
raft revascularization include aortic allograft and NAIS
econstruction with femoral-popliteal vein. These two in
itu revascularization techniques were initially developed
or management of aortic graft infection.32-35 These tech-
iques treated aortic graft infection successfully. Since then,
he authors have expanded these techniques in the manage-
ent of mycotic aneurysm and pseudoaneurysm.36-40 The
urgeons in our institution have no experience with allo-
raft or NAIS procedures. If graft infection develops after
n situ prosthetic graft reconstruction, the procedures men-
ioned above may be of benefit.
Retrospective data collection and small sample size are
mportant limitations in this study. Another limitation is a
election bias in the use of revascularization. The surgical
roup in our institution preferred in situ prosthetic graft in
febrile patients or in patients with good response to pre-
perative antibiotic therapy. The higher rate of nonvascular
omplications in the group II patients also strongly sug-
ests that group II patients who were treated with extra-
natomic bypass grafts were likely to have poor host im-
une response against sepsis or had more severe infection
han group I patients treated with in situ prosthetic grafts.
ONCLUSIONS
Our experience supports the finding that the long-term
utcomes are similar between the in situ prosthetic graft
nd extra-anatomic bypass groups, with the former having
ower late vascular-related complication and overall late
omplication rates in selective patients. Although providing
imilar long-term survival, extra-anatomic bypass has a
igher complication rate and should be considered for
hose patients who are unsuitable for in situ revasculariza-
ion. Further prospective study with large patient popula-
ions is needed to determine the selection criteria for using
n situ revascularization with the NAIS procedure, allo-
rafts, and synthetic grafts as alternative methods for treat-
ent of infected AAAs.
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